Fauci explains what the pause on the J&J vaccine means: 6 details

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said in an April 13 White House briefing that the FDA recommended a pause on the use of Johnson & Johnson’s vaccine, so they can investigate how six women developed a rare blood clotting disorder that resulted in one death, according to an April 13 report published by CNBC.

Advertisement

Six things to know about the pause:

  1. Dr. Fauci said the FDA and CDC want to see if there are “common denominators among the women who were involved.”
  2. The blood clotting disorder is known as cerebral venous sinus thrombosis, or CVST.
  3. The pause will allow physicians to be aware of how to treat CVST. Blood clots are normally treated with a blood thinner called heparin, but it can be dangerous in cases of CVST.
  4. Out of the 6.9 million people who have received the Johnson & Johnson vaccine, six are known to have developed blood clots.
  5. Dr. Fauci said the pause could last from a matter of days to a few weeks.
  6. The CDC will meet with the Advisory Committee on Immunization Practices on April 14 to further review the cases.

More articles on leadership and management:
Top 10 healthcare companies for social responsibility
6 resources for healthcare leaders on vaccine hesitancy

Dr. Patrizia Cavazzoni tapped as FDA’s top drug reviewer

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.